Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis
- PMID: 18667038
- DOI: 10.1111/j.1348-0421.2008.00051.x
Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis
Abstract
The contribution of the MexXY multidrug efflux system to aminoglycoside resistance was investigated in 18 clinical isolates of Pseudomonas aeruginosa obtained from dairy cows with Pseudomonas mastitis. All of the isolates expressed MexXY as determined by reverse transcription-PCR. The loss of mexXY resulted in increased susceptibility (two- to 16-fold decline in MIC) to aminoglycosides, confirming the contribution of this system in aminoglycoside resistance in these strains. As the impact of DeltamexXY varied, overexpression of MexXY alone is not sufficient for aminoglycoside resistance. Expression of mexXY also varied and did not strictly correlate with aminoglycoside insusceptibility. Transcription levels of mexY were independent on mutations in mexZ, suggesting the existence of additional regulatory mechanisms other than mexZ.
Similar articles
-
Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa.Clin Microbiol Infect. 2004 Oct;10(10):877-83. doi: 10.1111/j.1469-0691.2004.00991.x. Clin Microbiol Infect. 2004. PMID: 15373880
-
Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Clin Microbiol Infect. 2009 Jan;15(1):60-6. doi: 10.1111/j.1469-0691.2008.02097.x. Epub 2008 Dec 22. Clin Microbiol Infect. 2009. PMID: 19154484
-
In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin.Clin Microbiol Infect. 2006 May;12(5):426-32. doi: 10.1111/j.1469-0691.2006.01371.x. Clin Microbiol Infect. 2006. PMID: 16643518
-
Adaptive resistance to cationic compounds in Pseudomonas aeruginosa.Int J Antimicrob Agents. 2011 Mar;37(3):187-93. doi: 10.1016/j.ijantimicag.2010.11.019. Epub 2011 Feb 4. Int J Antimicrob Agents. 2011. PMID: 21295448 Review.
-
Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa.FEMS Microbiol Rev. 2009 Mar;33(2):279-94. doi: 10.1111/j.1574-6976.2008.00135.x. FEMS Microbiol Rev. 2009. PMID: 19243444 Review.
Cited by
-
Resistance, mechanism, and fitness cost of specific bacteriophages for Pseudomonas aeruginosa.mSphere. 2024 Feb 28;9(2):e0055323. doi: 10.1128/msphere.00553-23. Epub 2024 Feb 1. mSphere. 2024. PMID: 38299825 Free PMC article.
-
Impact of recA on levofloxacin exposure-related resistance development.Antimicrob Agents Chemother. 2010 Oct;54(10):4262-8. doi: 10.1128/AAC.00168-10. Epub 2010 Jul 26. Antimicrob Agents Chemother. 2010. PMID: 20660686 Free PMC article.
-
Antimicrobial Resistance in Acinetobacter spp. and Pseudomonas spp.Microbiol Spectr. 2018 Jun;6(3):10.1128/microbiolspec.arba-0007-2017. doi: 10.1128/microbiolspec.ARBA-0007-2017. Microbiol Spectr. 2018. PMID: 30101740 Free PMC article. Review.
-
Determination of Pseudomonas aeruginosa MexXY-OprM substrate profile in a major efflux knockout system reveals distinct antibiotic substrate classes.bioRxiv [Preprint]. 2024 Nov 20:2024.10.18.619101. doi: 10.1101/2024.10.18.619101. bioRxiv. 2024. Update in: Microbiol Spectr. 2025 Mar 04;13(3):e0290324. doi: 10.1128/spectrum.02903-24. PMID: 39605423 Free PMC article. Updated. Preprint.
-
Effects of the order of exposure to antimicrobials on the incidence of multidrug-resistant Pseudomonas aeruginosa.Sci Rep. 2023 May 31;13(1):8826. doi: 10.1038/s41598-023-35256-8. Sci Rep. 2023. PMID: 37258635 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials